Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease. | Arch Toxicol | 2020 | 31919559 | PubTator, text mining | PubMed |
| A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia. | Blood Cancer J | 2020 | 31913266 | PubTator, text mining | PubMed |
| A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer. | Oncol Lett | 2020 | 31897161 | PubTator, text mining | PubMed |
| Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B. | Cancer Med | 2020 | 31856414 | PubTator, text mining | PubMed |
| Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma. | Br J Cancer | 2020 | 31839677 | PubTator, text mining | PubMed |
| Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. | Food Chem Toxicol | 2020 | 31838189 | PubTator, text mining | PubMed |
| Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old. | Int J Surg Pathol | 2020 | 31801397 | PubTator, text mining | PubMed |
| A GM1b/asialo-GM1 oligosaccharide-binding R-type lectin from purplish bifurcate mussels Mytilisepta virgata and its effect on MAP kinases. | FEBS J | 2020 | 31769916 | PubTator, text mining | PubMed |
| Significance of alternative splicing in cancer cells. | Chin Med J (Engl) | 2020 | 31764175 | PubTator, text mining | PubMed |
| Identification of the key differentially expressed genes and pathways involved in neutrophilia. | Innate Immun | 2020 | 31726910 | PubTator, text mining | PubMed |
| ATR-FTIR spectroscopy and CDKN1C gene expression in the prediction of lymph nodes metastases in papillary thyroid carcinoma. | Spectrochim Acta A Mol Biomol Spectrosc | 2020 | 31708464 | PubTator, text mining | PubMed |
| Regulation of stimulus-induced interleukin-8 gene transcription in human adrenocortical carcinoma cells - Role of AP-1 and NF-κB. | Cytokine | 2020 | 31634687 | PubTator, text mining | PubMed |
| A role for peroxiredoxins in H2O2- and MEKK-dependent activation of the p38 signaling pathway. | Redox Biol | 2020 | 31629169 | PubTator, text mining | PubMed |
| Kinome expression profiling to target new therapeutic avenues in multiple myeloma. | Haematologica | 2020 | 31289205 | PubTator, text mining | PubMed |
| Prmt7 promotes myoblast differentiation via methylation of p38MAPK on arginine residue 70. | Cell Death Differ | 2020 | 31243342 | PubTator, text mining | PubMed |
| Neuraxial Cytokines in Pain States. | Front Immunol | 2019 | 32047493 | PubTator, text mining | PubMed |
| Pigment Epithelium-Derived Factor Promotes the Growth and Migration of Human Esophageal Squamous Cell Carcinoma. | Front Oncol | 2019 | 32010619 | PubTator, text mining | PubMed |
| BICP0 Negatively Regulates TRAF6-Mediated NF-κB and Interferon Activation by Promoting K48-Linked Polyubiquitination of TRAF6. | Front Microbiol | 2019 | 31969874 | PubTator, text mining | PubMed |
| Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancer. | J Exp Clin Cancer Res | 2019 | 31881903 | PubTator, text mining | PubMed |
| Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). | Cells | 2019 | 31842391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=40